• LAST PRICE
    0.2600
  • TODAY'S CHANGE (%)
    Trending Down-0.0246 (-8.6437%)
  • Bid / Lots
    0.2630/ 10
  • Ask / Lots
    0.2699/ 1
  • Open / Previous Close
    0.2800 / 0.2846
  • Day Range
    Low 0.2510
    High 0.2800
  • 52 Week Range
    Low 0.2510
    High 9.1109
  • Volume
    315,805
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.2846
TimeVolumeVIRI
09:32 ET82000.27
09:42 ET270220.251
09:51 ET1090.255
09:55 ET3460.2572
10:00 ET9890.257499
10:04 ET1000.257499
10:06 ET12290.2551
10:15 ET53830.251
10:24 ET160000.27
10:29 ET136300.268275
10:36 ET1000.269799
10:40 ET110980.2525
10:42 ET4790.2699
10:45 ET1000.26245
11:25 ET14820.2625
11:30 ET60000.2601
11:32 ET60000.262399
11:34 ET11080.255
11:36 ET1000.2623
11:39 ET30000.255
11:45 ET1220.25865
12:08 ET10000.26
12:14 ET21000.2622
12:17 ET1000.2625
12:21 ET25000.2624
12:39 ET3000.2623
12:48 ET1000.26065
12:50 ET4180.2623
12:51 ET4500.2624
01:04 ET1000.2624
01:20 ET4500.2624
01:22 ET10000.262299
01:24 ET1000.2623
01:29 ET6000.2624
01:36 ET6000.2624
01:47 ET1000.2624
01:49 ET1000.2624
01:51 ET75000.2624
01:56 ET3450.261993
02:23 ET117820.26
02:27 ET1000.2599
02:34 ET24000.259975
02:39 ET3450.26
03:03 ET40000.259896
03:10 ET1000.2599
03:12 ET1000.2599
03:26 ET71280.2612
03:39 ET1283780.26
03:42 ET99000.2599
03:44 ET49810.2589
03:50 ET5000.261199
03:55 ET1000.2624
03:57 ET32440.26
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVIRI
Virios Therapeutics Inc
5.2M
-0.2x
---
United StatesBVXV
BiondVax Pharmaceuticals Ltd
18.5M
-1.2x
---
United StatesRNAZ
Transcode Therapeutics Inc
5.4M
-0.8x
---
United StatesCWBR
CohBar Inc
5.0M
-0.4x
---
United StatesPHIO
Phio Pharmaceuticals Corp
5.5M
-0.4x
---
United StatesCFRX
ContraFect Corp
5.5M
-0.1x
---
As of 2022-12-07

Company Information

Virios Therapeutics, Inc. is a development-stage biotechnology company focused on advancing antiviral therapies to treat debilitating chronic diseases such as fibromyalgia (FM). The Company’s lead development candidate is IMC-1, which is a fixed dose combination of famciclovir, and celecoxib designed to synergistically suppress herpes virus replication. IMC-1 combines these two specific mechanisms of action purposely designed to inhibit herpes virus activation and replication. The Company’s pipeline product includes IMC-2 (valacyclovir and celecoxib), which is in the Phase 1 development stage. IMC-2 (valacyclovir and celecoxib) is developed for treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with Long-COVID or Post-Acute Sequelae of COVID-19 (PASC).

Contact Information

Headquarters
44 Milton AvenueALPHARETTA, GA, United States 30009
Phone
---
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Gregory Duncan
Founder, Director
William Pridgen
Senior Vice President - Finance
Angela Walsh
Senior Vice President of Operations
Ralph Grosswald
Chief Medical Officer
R. Michael Gendreau

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.2M
Revenue (TTM)
$0.00
Shares Outstanding
18.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.60
Book Value
$1.74
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.